Nuclear Radiology: Page 19

FDG-PET displays its prowess in dementia detection

By Wayne Forrest

In a direct comparison, FDG-PET proved superior to MRI with arterial spin labeling for diagnosing and differentiating various forms of dementia; however, there remains a need for the latter modality, a new Belgian study has found.

February 3, 2020

U.K. officially withdraws from the EMA

By AuntMinnieEurope.com staff writers

As of 1 February, delegates from the U.K. are no longer allowed to participate in meetings organized by the scientific communities, working parties, or management board of the European Medicines Agency (EMA).

February 2, 2020

Timing tests promise to improve PET performance

By Susan Curtis

Researchers at CERN, the European Organization for Nuclear Research, have placed new limits on the timing performance of systems for time-of-flight PET. Their aim is to enhance the quality of PET images, enabling doctors to reduce the dose of radioactive tracer they administer to patients.

January 30, 2020

Viennese biomarker study casts light on breast cancer risk

By Brian Casey

Austrian investigators have used PET and MRI to find out that patients with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. They examined 141 women who had imaging abnormalities in one breast and a tumor-free contralateral breast.

January 23, 2020

Shine reports Lu-177 production milestone

By AuntMinnieEurope.com staff writers

Medical isotope firm Shine Medical Technologies and partners GE Healthcare and the Institute of Organic Chemistry and Biochemistry in the Czech Republic said they have produced patient dose quantities of the lutetium-177 (Lu-177) therapeutic isotope.

January 20, 2020

PET strengthens case for cause of schizophrenia

By Wayne Forrest

By combining PET imaging with a radiotracer that binds to a specific protein, U.K. researchers may have validated the belief that dysfunctional neuronal connections in the brain are the underlying cause of schizophrenia, according to a study published on 14 January in Nature Communications.

January 16, 2020

Report: Fujifilm makes pitch for Curium Pharma

By Wayne Forrest

In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as 2.7 billion euros, according to a 14 January report from Bloomberg.

January 15, 2020

LMI highlights research on PET neuroimaging tracers

By AuntMinnieEurope.com staff writers

Berlin-based Life Molecular Imaging (LMI) is unveiling new study findings on its PET neuroimaging tracers through nine different presentations at this week's Human Amyloid Imaging meeting in Miami, Florida, U.S.

January 15, 2020

U.S. DOE waives export ban on highly enriched uranium

By AuntMinnieEurope.com staff writers

The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.

January 8, 2020

Dutch refine use of PET to predict cancer therapy outcome

By Wayne Forrest

Researchers from the Netherlands are edging closer to proving the value of zirconium-89 immuno-PET as a noninvasive approach to predicting the effectiveness of therapy for cancerous tumors. Their findings have appeared in the December edition of the Journal of Nuclear Medicine.

December 19, 2019

Affidea, Subtle Medical partner for PET/CT

By AuntMinnieEurope.com staff writers

Diagnostic imaging, outpatient, and cancer care services provider Affidea and imaging artificial intelligence software developer Subtle Medical have formed a strategic partnership to improve the patient experience during PET/CT scans.

December 16, 2019

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

December 15, 2019

Previous Page

Page 19 of 90

Next Page